Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02629731 · ClinicalTrials.gov registry record · NA
Orthotic Dose Response Study
A NA study of Ankle Osteoarthritis and Flat Foot or Pes Planus, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 2
- Study locations
NCT02629731: Completed NA study of Ankle Osteoarthritis and Flat Foot or Pes Planus, sponsored by VA Office of Research and Development.
NCT02629731 is a NA study of Ankle Osteoarthritis and Flat Foot or Pes Planus that has completed, run by VA Office of Research and Development. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02629731, a NA study of Ankle Osteoarthritis and Flat Foot or Pes Planus, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will investigate the effect of foot orthoses on two common conditions (ankle osteoarthritis and symptomatic adult onset flat feet) by using a custom biplane X-ray system the group has developed to very accurately and precisely quantify foot bone motion. The investigators will vary the design of the orthoses and subjects will be examined to find out which are most effective at improving function.
Primary Outcome
In the proposed experiments, normal and pathological subjects will be studied while they walk with seven different designs of in-shoe orthoses in standardized footwear. Subjecting individuals to different "doses" of orthotic correction will generate "dose-response" curves (i.e., the kinematic variables) that will then be associated with patient-specific characteristics.
Conditions Studied
Interventions
- DEVICE custom orthoses with varying degrees of hindfoot posting
Study Locations (2)
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2023-12-29 |
| Phase | NA |
What the finished NCT02629731 record still lists
NCT02629731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Ankle Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which custom orthoses with varying degrees of hindfoot posting is the first listed.
NCT02629731 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT02629731 about?
NCT02629731 is a clinical study titled "Orthotic Dose Response Study". This study will investigate the effect of foot orthoses on two common conditions (ankle osteoarthritis and symptomatic adult onset flat feet) by using a custom biplane X-ray system the group has developed to very accurately and precisely quantify foot bone motion. The investigators will vary the des...
What is the current status of trial NCT02629731?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-07-01. Estimated completion is 2023-12-29.
What conditions does trial NCT02629731 study?
This clinical trial studies the following conditions: Ankle Osteoarthritis, Flat Foot or Pes Planus.
What interventions are being tested in trial NCT02629731?
The interventions under investigation include: custom orthoses with varying degrees of hindfoot posting (DEVICE).
Who is sponsoring clinical trial NCT02629731?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02629731 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ankle Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02629731's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI